AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 45 filers reported holding AMBRX BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.56 and the average weighting 1.4%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,486,386 | $22,452,000 | 1.34% |
| Fosun International Ltd | 1,932,591 | $17,451,000 | 1.00% |
| Octagon Capital Advisors LP | 336,868 | $3,042,000 | 0.59% |
| Artal Group S.A. | 2,152,291 | $19,435,000 | 0.53% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,057,735 | $9,551,000 | 0.18% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,923,700 | $17,371,000 | 0.03% |
| FMR LLC | 3,855,025 | $34,811,000 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 20,143 | $182,000 | 0.00% |
| CAAS CAPITAL MANAGEMENT LP | 13,068 | $118,000 | 0.00% |
| BlackRock Inc. | 2,869,486 | $25,912,000 | 0.00% |